Our results show hepatic Nrf1 is important for preventing MASH-linked hepatocyte proliferation, liver inflammation, and HCC, that actions by Nrf1 and Nrf2 synergistically reduce hepatic lipid storage, and that the Nrf2-inducing drug bardoxolone alleviates liver inflammation and fibrosis. This evidence concerns the gene NRF1 and inflammation.